Home Patient Information         Important Safety Info        Health Care Professionals   
Erection Quality
ED & High Cholesterol
ED & High Blood Pressure
ED & Diabetes
About Your Doctor Visit
Doctor Discussion Guide
Sexual Health Checklist
SHIM Questionnaire
Talk About It
About LEVITRA
Information for Partners
Special Offers
Sign Up for Your Free Men’s Facts Kit
LEVITRA (Vardenafil HCl)
Sexual Health Inventory for Men (SHIM)
This questionnaire is an assessment tool designed to help you and your doctor determine if you are having erection problems that may be classified as erectile dysfunction (ED).

Each question has several possible responses. Choose the response that best describes your own situation.

If your score indicates that you have signs of erectile dysfunction, share it with your doctor. He may recommend ways to improve erectile function.

Over the past six months:

1. 
How do you rate your confidence that you could get and keep an erection?
Very low
Low
Moderate
High
Very high
2. When you had erections with sexual stimulation, how often were your erections hard enough for penetration (entering your partner)?
No sexual activity
Almost never or never
A few times (much less than half the time)
Sometimes (about half the time)
Most times (much more than half the time)
Almost always or always
3. During sexual intercourse, how often were you able to maintain your erection after you had penetrated (entered) your partner?
Did not attempt intercourse
Almost never or never
A few times (much less than half the time)
Sometimes (about half the time)
Most times (much more than half the time)
Almost always or always
4. During sexual intercourse, how difficult was it to maintain your erection to completion of intercourse?
Did not attempt intercourse
Extremely difficult
Very difficult
Difficult
Slightly difficult
Not difficult
5. When you attempted sexual intercourse, how often was it satisfactory for you?
Did not attempt intercourse
Almost never or never
A few times (much less than half the time)
Sometimes (about half the time)
Most times (much more than half the time)
Almost always or always

 

This tool is the Sexual Health Inventory for Men (SHIM). Nothing in this questionnaire should be construed as the giving of medical advice or the making of a recommendation, and the questionnaire should not be relied on as the basis for any decision or action. It is important that you rely only on a health care professional to advise you on health matters.

 
Important Safety and Dosing Information

LEVITRA is a prescription medicine that is used to treat erectile dysfunction (ED). Men taking nitrate drugs, often used to control chest pain (also known as angina), should not take LEVITRA. Such combinations could cause blood pressure to drop to an unsafe level.

As with all ED drugs, there is a rare risk of an erection lasting longer than four hours. To avoid long-term injury, seek immediate medical attention. LEVITRA does not protect against sexually transmitted diseases. In rare instances, men taking PDE5 inhibitors (oral erectile dysfunction medicine, including LEVITRA) reported a sudden decrease or loss of vision in one or both eyes, or a sudden loss or decrease in hearing, sometimes with ringing in the ears and dizziness. It is not possible to determine whether these events are related directly to these medicines or to other factors. If you experience any of these symptoms, stop taking PDE5 inhibitors, including LEVITRA, and call a doctor right away.

Discuss your medical conditions, including heart problems, and medications, including alpha blockers prescribed for prostate problems or high blood pressure, with your doctor to ensure LEVITRA is right for you and that you are healthy enough for sexual activity. LEVITRA is not recommended for men with uncontrolled high blood pressure.

The starting dose of LEVITRA is 10 mg taken no more than once per day. Your doctor will decide the dose that is right for you. In patients taking alpha blockers, your doctor may start you on a lower dose of LEVITRA. In patients taking certain medications such as ritonavir, indinavir, saquinavir, atazanavir, ketoconazole, itraconazole, erythromycin and clarithromycin, lower doses of LEVITRA are recommended, and time between doses of LEVITRA may need to be extended.

In clinical trials, the most commonly reported side effects were headache, flushing, and stuffy or runny nose. LEVITRA is available in 2.5-mg, 5-mg, 10-mg, and 20-mg tablets.

Please see complete Prescribing Information for 2.5-mg, 5-mg, 10-mg, and 20-mg LEVITRA ® (vardenafil HCl).
[Requires Adobe® Reader® - click here to download]

   Adobe is a registered trademark of Adobe Systems Incorporated.

This site is intended for U.S. residents only.

©2004-2007 Bayer Pharmaceuticals Corporation. All Rights Reserved. GlaxoSmithKline and Schering Corporation.



Legal Notices | Privacy Statement | Contact Us | Site Map
Bayer HealthCare Pharmaceuticals GlaxoSmithKline Schering-Plough